Prevalence of clinical and isolated subclinical cardiovascular disease in older adults with glucose disorders: the Cardiovascular Health Study. - Wikidata - awgldk - TriplyDB

Prevalence of clinical and isolated subclinical cardiovascular disease in older adults with glucose disorders: the Cardiovascular Health Study.

Prevalence of clinical and isolated subclinical cardiovascular disease in older adults with glucose disorders: the Cardiovascular Health Study.

http://www.wikidata.org/entity/Q43651884

about

Evolution of target organ damage and haemodynamic parameters over 4 years in patients with increased insulin resistance: the LOD-DIABETES prospective observational study Cardiovascular comorbidities among public health clinic patients with diabetes: the Urban Diabetics Study Xuezhikang Capsule for Type 2 Diabetes with Hyperlipemia: A Systematic Review and Meta-Analysis of Randomized Clinical Trails A novel transcriptional mechanism of cell type-specific regulation of vascular gene expression by glucose Atherosclerotic cardiovascular disease in older adults with diabetes mellitus HIV and general cardiovascular risk.Serum leptin and its relation to anthropometric measures of obesity in pre-diabetic Saudis Age- and gender-specific awareness, treatment, and control of cardiovascular risk factors and subclinical vascular lesions in a founder population: the SardiNIA Study Lipoprotein-associated phospholipase A(2) and future risk of subclinical disease and cardiovascular events in individuals with type 2 diabetes: the Cardiovascular Health Study.Diabetes and stroke prevention: a review.An evaluation of glucose tolerance in essential hypertension.The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance.Diabetes, insulin resistance and atherosclerosis surrogates in patients with coronary atherosclerosis Imaging of hypoxia in mouse atherosclerotic plaques with (64)Cu-ATSM.Prevalence of cardiovascular risk factors in youth with type 1 diabetes and elevated body mass index.Metabolic Burden and Disease and Mortality Risk Associated with Impaired Fasting Glucose in Elderly Adults.Cardiovascular outcomes using doxazosin vs. chlorthalidone for the treatment of hypertension in older adults with and without glucose disorders: a report from the ALLHAT study.The association of markers of inflammation with weight change in older adults: the Cardiovascular Health Study.Differential MMP-9 activity in CD34⁺progenitor cell-derived foam cells from diabetic and normoglycemic patients.Effect of hyperlipidemia on the incidence of cardio-cerebrovascular events in patients with type 2 diabetes.

P2860

Q24658535-0A3D55ED-5577-4687-8AE8-3BCA5F717D41 Q24795220-A9B69B5F-A545-4BA6-B056-D232838C50E9 Q26798199-1AB8E8D7-CABD-4268-A3E2-EB218B40DD6E Q28393095-C703F0C6-600A-4086-8598-08B67D518D4C Q34626489-62B75A2F-743F-4442-85DA-6C0560C41C18 Q35118909-E55B1DFE-0DE4-437D-824C-F60C02DB524A Q35914633-EBA830AA-20C1-4097-A660-F31914520BAB Q36317004-AEC57217-90FD-4FDA-A076-CC65D5F70D82 Q36371844-F21A192F-34A9-4F92-A467-11A077CC27E9 Q36528473-D814D688-EEF1-47B6-82D3-B79E373179AF Q37183257-D4D4D926-0040-4F5A-8C5F-31E4E2EDCA43 Q37240093-7B2472A4-9164-46BC-8D54-901149DABD7E Q39246081-81FCBF93-A3BC-4A1F-AC49-61A7C94CA8B8 Q39636702-ACB72DAE-36BC-433E-AF36-6F71C3428640 Q40833138-95BFD981-53A5-47F1-B3B0-575B57BA0C95 Q41610251-B5D91251-082C-4880-9EBA-CD5583EC2AE2 Q44793011-FBFFEA0B-A2D2-4877-BF11-9347FD74796B Q47345994-DB774A40-D390-49A7-AE8E-4D7AE725E906 Q54489626-407132A8-F2A5-46F9-9541-5437FD25B5ED Q55285078-83FF0183-3C41-4444-AF54-0FB8ECEC1091

P2860

Prevalence of clinical and isolated subclinical cardiovascular disease in older adults with glucose disorders: the Cardiovascular Health Study.

http://www.wikidata.org/entity/Q43651884

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh

2001年學術文章

@zh-hant

name

Prevalence of clinical and iso ...... e Cardiovascular Health Study.

@en

Prevalence of clinical and iso ...... e Cardiovascular Health Study.

@nl

type

label

Prevalence of clinical and iso ...... e Cardiovascular Health Study.

@en

Prevalence of clinical and iso ...... e Cardiovascular Health Study.

@nl

prefLabel

Prevalence of clinical and iso ...... e Cardiovascular Health Study.

@en

Prevalence of clinical and iso ...... e Cardiovascular Health Study.

@nl

P1433

Q43651884-D39383C8-C2A4-4F19-BCF9-5D7CCF15706D

P1476

Q43651884-BF017C78-EB85-45F0-89D7-1A62FB817521

P2093

Q43651884-0043F14B-CDEA-467C-B914-F17E587C89F1

Q43651884-2D79FE36-9032-4AB0-876F-30B5D5050D1C

Q43651884-3BDEC28A-83FF-49D5-B7A3-D3432BA386F5

Q43651884-9ABFB066-6F86-4E27-9F77-1959DF45A90F

Q43651884-B05485D4-34B8-4985-B442-FD812E8F5F3C

Q43651884-BE0207FB-B86B-49AD-8024-CD4604446E5F

Q43651884-C3C680F8-5C00-44B6-8C84-B61DE671F304

Q43651884-D05FCD09-E4D9-4E33-B026-B8A076D18981

Q43651884-D48891F9-E0A6-46CA-AF72-8E738E13A98E

Q43651884-DB4F6AB9-F701-4043-8C71-CE2D56C4D91B

P304

Q43651884-8FFD32DD-7E52-4BA0-82C3-58A223B53DA3

P31

Q43651884-E0847552-33C1-4093-9314-04C9CF3B8981

P356

Q43651884-FCAB216F-EC49-463C-A4F6-D0AEA24003E3

P407

Q43651884-1501C1B9-2957-421D-AA97-987A5EF8F310

P433

Q43651884-99BB8235-7752-4AEA-84E1-8B2AB215FE32

P478

Q43651884-78C197CE-A3FD-4421-893F-26C22693A343

P577

Q43651884-024CE5CF-7CD7-40BD-B4A8-FFDCC6F86848

P5875

Q43651884-9A466E96-7235-4395-9CD0-3AAE67ACDE70

P698

Q43651884-93F9CD4C-B735-4C57-BADE-82000511DDBC

P921

Q43651884-0A235A19-AFDC-49BC-8017-D541684C33B9

Q43651884-2ab3b971-05cf-4c31-8028-e57b06c320b3

Q43651884-8E8D6EE9-859E-4A4F-AC8D-8D7248DE4E7E

P356

DIACARE.24.7.1233

P1433

P1476

Prevalence of clinical and iso ...... e Cardiovascular Health Study.

@en

P2093

C F Spiekerman

http://www.w3.org/2001/XMLSchema#string

Cardiovascular Health Study

http://www.w3.org/2001/XMLSchema#string

D H O'Leary

http://www.w3.org/2001/XMLSchema#string

F L Brancati

http://www.w3.org/2001/XMLSchema#string

G L Burke

http://www.w3.org/2001/XMLSchema#string

J I Barzilay

http://www.w3.org/2001/XMLSchema#string

J S Gottdiener

http://www.w3.org/2001/XMLSchema#string

L H Kuller

http://www.w3.org/2001/XMLSchema#string

P J Savage

http://www.w3.org/2001/XMLSchema#string

T J Orchard

http://www.w3.org/2001/XMLSchema#string

P304

1233-1239

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DIACARE.24.7.1233

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

2001-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11916073

http://www.w3.org/2001/XMLSchema#string

P698

11423508

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease